CClinicalTrials.gg
CompletedNCT01783912Updated Feb 29, 2016Results posted

Helping Those With Mental Illness Quit Smoking

A Phase 4 interventional study of Cognitive / Motivational Individual Sessions and Attention Control Individual Sessions in Smoking, Nicotine Dependence and Mental Disorders, sponsored by University of Wisconsin, Madison. Completed at 1 site in United States. Open to participants aged 18 Years to 99 Years. Per ClinicalTrials.gov, last updated 2016-02-29.

Sponsored by University of Wisconsin, Madison · Phase 4, Interventional, and Treatment

Phase
Phase 4
Study type
Interventional
Enrollment
270
Allocation
Randomized
Ages
18 Years to 99 Years
Sex
All
01

Study summary

This study tests whether pre-cessation interventions known to be effective in the general population will increase acceptance of evidence-based treatment, engagement and compliance with that treatment and initial quitting success. One hundred and seventy two patients will be recruited from 13 Community Support Programs (CSPs). CSPs provide community based care to those diagnosed with persistent and serious mental illness. All participants will receive two group sessions (40 minutes each) modeled after "Kicking Butts", a group-based quitting preparation program used for the past four years in two Milwaukee CSP programs run by Wisconsin Community Services. Individuals will then be randomly assigned to the experimental and control conditions (n=86 each). Experimental subjects will receive four evidence-based preparatory interventions (motivational interviewing, smoking reduction, practice quit attempt, and pre-quit use of nicotine replacement medication) (25 - 30 minutes each). Attention control subjects will also receive four individual sessions of the same duration. However their individual sessions' content will be a discussion of the personal relevance of the group material and will not include any of the preparatory interventions. Data will be collected via brief surveys taken pre-intervention, at the end of the last individual session, and three months later and from a database provided by the Wisconsin Tobacco Quit Line (WTQL).

02

Conditions studied

  • Smoking
  • Nicotine Dependence
  • Mental Disorders

Keywords

  • Smoking
  • Nicotine Dependence
  • Mental Disorders
03

In context

Tobacco Use Disorder

968 studies on the registry are indexed under Tobacco Use Disorder; 126 are open to participants now.

This study's enrollment of 270 is above the median of 89 across 851 interventional studies indexed under Tobacco Use Disorder.

Browse Tobacco Use Disorder studies →

Lead sponsor

University of Wisconsin, Madison is the lead sponsor of 1,161 studies on the registry; 182 are open to participants now.

Of its 151 completed or terminated interventional studies of FDA-regulated products, 114 (75%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 99 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • current smoker (smoking daily or smoking at least 10 cigarettes per week) (use of other tobacco products permitted such as chew and snuz in addition to smoking)
  • not willing to make a quit attempt
  • willingness to use the nicotine patch
  • plans to remain in the area for the next five four months.

Exclusion criteria

Exclusion Criteria:

  • current use of any cessation medicine (nicotine patch, nicotine gum, nicotine lozenge, nicotine inhaler, nicotine nasal spray, bupropion, Wellbutrin, Zyban,Chantix or varenicline)
  • previous serious skin reaction or other allergic reaction to using the nicotine patch
  • stroke, heart attack or abnormal electrocardiogram in past four weeks
  • pregnancy, plans to get pregnant or nursing
  • exclusive use of other tobacco products (non-smoker tobacco user)
  • having a court-ordered guardian, or an activated power of attorney for health or observation by researchers during the consent procedure that suggests diminished decision making capacity
05

Study design

Phase
Phase 4
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Factorial assignment
Masking
Single (Participant)
Enrollment
270 participants (actual)

Study arms

  • Experimental
    Cognitive/Motivational Intervention Group

    This arm of the project will address the following questions: After completion of experimental individual sessions, do the participants in the control group utilize the quit line services at the same, greater or lesser rate than those who are in the Active Control group? After completion of experimental individual sessions, do the participants in the control group utilize the quit line services at the same, greater or lesser rate than those who are in the Motivated Smokers Comparison group?

    Behavioral: Cognitive / Motivational Individual Sessions · Drug: Nicotine Patch · Behavioral: Group Curriculum

  • Active comparator
    Attention Control Group

    This arm of the project will address the following question: After completion of control individual sessions, do the participants in the control group utilize the quit line services at the same, greater or lesser rate that those who are in the experimental treatment group? After completion of control individual sessions, do the participants in the control group utilize the quit line services at the same, greater or lesser rate than those who are in the Cognitive/Motivational Intervention Group?

    Behavioral: Attention Control Individual Sessions · Behavioral: Group Curriculum

  • No intervention
    Motivated Smokers Comparison Group

    This arm of the project will address the following question: Do participants in the Motivated Smokers Comparison group (identified as motivated to quit upon recruitment) utilize the quit line services at the same, greater or lesser rate than those who are in the Motivated Smokers Comparison group? Do participants in the Motivated Smokers Comparison group (identified as motivated to quit upon recruitment) utilize the quit line services at the same, greater or lesser rate than those who are in the Active Control group? Participants will not receive any intervention but will be consented and enrolled into this group and assessed for utilization of the tobacco quit line services.

Interventions

  • BehavioralCognitive / Motivational Individual Sessions

    Cognitive Motivational subjects will receive four evidence-based preparatory interventions (motivational interviewing, smoking reduction, practice quit attempt, and pre-quit use of nicotine replacement medication) (25 - 30 minutes each).

  • BehavioralAttention Control Individual Sessions

    Attention control subjects will receive four placebo individual sessions (25-30 minutes each). The session content will reemphasize group discussion of the personal health risks from smoking.

  • DrugNicotine Patch

    Cognitive Motivational subjects will be asked to take one 21 mg patch/day for 4 weeks.

  • BehavioralGroup Curriculum

    Everyone to be put into the experimental or active comparator group will attend 2 group meetings over two weeks each of which lasts 40 minutes. Experience with the Kicking Butts program indicates that this duration is well tolerated by this population. The content of these two group meetings is based on the Kicking Butts program. The Kicking Butts program was initially developed as a cessation intervention, but consistent with the literature about the need to prepare this population to make a quit attempt, has evolved to emphasize preparation for quitting. Topics addressed include the health consequences of smoking, reasons to quit and methods of quitting.

06

What researchers measure

Primary outcomes

  1. Acceptance of Wisconsin Tobacco Quit Line Services

    The primary outcome is participant acceptance of evidence based treatment through the WTQL at the end of the last individual session.

    Time frame: 4-6 weeks after study enrollment

07

Results

Posted Feb 1, 2016

Participant flow

Participant flow — Overall Study
MilestoneCognitive/Motivational Intervention GroupAttention Control GroupMotivated Smokers Comparison Group
Started11810448
Completed885825
Not completed304623

Outcome measures

PrimaryAcceptance of Wisconsin Tobacco Quit Line Services

The primary outcome is participant acceptance of evidence based treatment through the WTQL at the end of the last individual session.

Time frame:
4-6 weeks after study enrollment
Reported as:
Number · participants
Acceptance of Wisconsin Tobacco Quit Line Services
participantsCognitive/Motivational Intervention GroupAttention Control GroupMotivated Smokers Comparison Group
Acceptance of Wisconsin Tobacco Quit Line Services1166

Adverse events

Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Cognitive/Motivational Intervention Group—0/118 (0%)0/118 (0%)
Attention Control Group—0/104 (0%)0/104 (0%)
Motivated Smokers Comparison Group—0/48 (0%)0/48 (0%)

Baseline characteristics

Age, Continuous
Age, Continuous(years)Cognitive/Motivational Intervention GroupAttention Control GroupMotivated Smokers Comparison GroupTotal
Mean43.8 ± 9.8843.6 ± 10.0545.0 ± 9.5444.0 ± 9.87
Sex: Female, Male
Sex: Female, Male(Participants)Cognitive/Motivational Intervention GroupAttention Control GroupMotivated Smokers Comparison GroupTotal
Female584824130
Male605624140
Region of Enrollment
Region of Enrollment(participants)Cognitive/Motivational Intervention GroupAttention Control GroupMotivated Smokers Comparison GroupTotal
United States11810448270
08

Study locations

1 site
  • University of Wisconsin Center for Tobacco Research and Intervention, School of Medicine and Public Health
    Madison, Wisconsin 53711, United States
09

References and documents

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 29, 2016, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT01783912
Lead sponsor
University of Wisconsin, Madison
Responsible party
Sponsor
First posted
Feb 5, 2013
Start date
Dec 2012
Primary completion
Jun 2014
Completion
Jun 2014
Results posted
Feb 1, 2016
Last update
Feb 29, 2016

Study contacts

Bruce Christiansen, PhD
principal investigator · University of Wisconsin School of Medicine and Public Health, Center for Tobacco Research and Intervention

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2016. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion